Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer
Closed for comments This consultation ended on at Request commenting lead permission
7 Diagnostics advisory committee members and NICE project team
Committee members
This topic was considered by the diagnostics advisory committee, which is a standing advisory committee of NICE.
Committee members are asked to declare any interests in the test to be evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.
The minutes of each committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
Additional specialist committee members took part in the discussions for this topic:
Specialist committee members
Mark Davies
Consultant in medical oncology and honorary consultant in clinical genetics, South West Wales Cancer Centre
Suzanne Frank
Advanced specialist breast cancer pharmacist, The Christie NHS Foundation Trust
Caroline Graham
Specialist lay committee member
Muireann Kelleher
Consultant medical oncologist, St. George's Healthcare NHS Foundation Trust
Britta Stordal
Senior Lecturer in medical sciences, Middlesex University London
NICE project team
Each diagnostics evaluation is assigned to a team consisting of a technical analyst (who acts as the topic lead), a technical adviser and a project manager.
Jacob Grant
Topic lead
Judith Shore
Technical adviser (until August 2023)
Frances Nixon
Technical adviser (from September 2023)
Donna Barnes
Project manager
ISBN:
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions